A detailed history of Huntleigh Advisors, Inc. transactions in Brainsway Ltd. stock. As of the latest transaction made, Huntleigh Advisors, Inc. holds 77,416 shares of BWAY stock, worth $1.2 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
77,416
Previous 73,273 5.65%
Holding current value
$1.2 Million
Previous $694 Million 46.71%
% of portfolio
0.2%
Previous 0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 29, 2025

BUY
$7.86 - $13.15 $32,563 - $54,480
4,143 Added 5.65%
77,416 $1.02 Billion
Q1 2025

Apr 29, 2025

BUY
$9.19 - $11.41 $96,531 - $119,850
10,504 Added 16.73%
73,273 $694 Million
Q4 2024

Apr 29, 2025

BUY
$8.96 - $10.86 $562,410 - $681,671
62,769 New
62,769 $592 Million

Others Institutions Holding BWAY

About Brainsway Ltd.


  • Ticker BWAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,519,200
  • Market Cap $255M
  • Description
  • Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...
More about BWAY
Track This Portfolio

Track Huntleigh Advisors, Inc. Portfolio

Follow Huntleigh Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntleigh Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Huntleigh Advisors, Inc. with notifications on news.